Cargando…
Selective Estrogen Receptor β Agonists: a Therapeutic Approach for HIV-1 Associated Neurocognitive Disorders
The persistence of HIV-1 associated neurocognitive disorders (HAND) in the post-cART era, afflicting between 40 and 70% of HIV-1 seropositive individuals, supports a critical need for the development of adjunctive therapeutic treatments. Selective estrogen receptor β agonists, including S-Equol (SE)...
Autores principales: | McLaurin, Kristen A., Moran, Landhing M., Booze, Rosemarie M., Mactutus, Charles F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7266801/ https://www.ncbi.nlm.nih.gov/pubmed/31858373 http://dx.doi.org/10.1007/s11481-019-09900-y |
Ejemplares similares
-
Neurorestoration of Sustained Attention in a Model of HIV-1 Associated Neurocognitive Disorders
por: Moran, Landhing M., et al.
Publicado: (2019) -
Microglial HIV-1 Expression: Role in HIV-1 Associated Neurocognitive Disorders
por: Li, Hailong, et al.
Publicado: (2021) -
HIV-1 mRNA Knockdown with CRISPR/Cas9 Enhances Neurocognitive Function
por: McLaurin, Kristen A, et al.
Publicado: (2023) -
HIV-Associated Apathy/Depression and Neurocognitive Impairments Reflect Persistent Dopamine Deficits
por: McLaurin, Kristen A., et al.
Publicado: (2021) -
Progression of temporal processing deficits in the HIV-1 transgenic rat
por: McLaurin, Kristen A., et al.
Publicado: (2016)